FURNISSO LTD

Company number 11929674 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: D-

The patient is in critical condition, suffering from chronic balance sheet insolvency and severe liquidity anemia. While the business is still breathing (actively trading), its financial vital signs are heavily reliant on the life support of creditor forbearance. Without an immediate capital transfusion, the company remains at high risk of cardiac arrest (insolvency).


1. Key Vital Signs

Pulse & Blood Pressure (Liquidity & Working Capital) Current Assets: £70,762 | Current Liabilities: £98,598 | Net Current Liabilities: (£27,836) The company’s pulse is dangerously weak. A healthy business maintains positive working capital to pump cash through its operations. Here, current liabilities drastically exceed current assets, resulting in a Current Ratio of roughly 0.71. This means for every £1 of short-term debt, the company only has 71p in liquid assets to pay it. The business is effectively gasping for financial air.

Weight & Muscle Mass (Net Assets & Equity) Total Assets: £75,614 | Total Liabilities: £98,598 | Net Assets: (£23,404) The business is severely underweight. Net assets are deeply negative, indicating that the company owes over £23,000 more than it owns. This is a classic symptom of "balance sheet insolvency"—a condition where, if all creditors demanded payment tomorrow, the company could not survive.

Cholesterol Levels (Debt Accumulation) Creditors due within one year: £98,598 (up from £88,598 in 2024) Short-term debt is clogging the company's arteries. Creditors have increased by over 11% year-on-year, suggesting the business is delaying payments to suppliers to preserve cash. This reliance on creditor financing is a high-risk symptom that can lead to restricted supply terms or legal demands.

Vitals Monitor (Financial Trend) Net Assets History: £11,735 (2021) ➝ £10,613 (2022) ➝ -£5,401 (2023) ➝ -£22,930 (2024) ➝ -£23,404 (2025) The patient's health has been deteriorating steadily over the last three years. The transition from positive equity in 2022 to a deepening hole of negative equity in 2025 shows a persistent hemorrhage of value, with cumulative losses eating away at the company's financial foundation.


2. Diagnosis

Chronic Balance Sheet Insolvency & Severe Liquidity Anemia FURNISSO LTD is suffering from a structural financial illness. The diagnosis is clear: the company is technically insolvent on a balance sheet basis, as its liabilities exceed its assets.

The underlying pathology appears to be unprofitable trading. Over the past three years, the business has sustained cumulative losses that have eroded its equity reserves and forced it to rely heavily on unsecured creditor funding. The fact that there are zero employees suggests this is likely a director-owned/operated micro-entity, meaning the £98.5k in current liabilities is almost certainly owed to trade suppliers, HMRC, or the directors themselves.

However, there is a faint positive sign in the latest ECG: Net current liabilities slightly improved from (£28,577) in 2024 to (£27,836) in 2025, and total assets grew from £66,208 to £75,614. This indicates the business is generating some top-line activity and holding more stock or debtors, but it is still not generating enough profit to clear its debt burden.


3. Recommendations

To stabilize the patient and prevent terminal decline, the following emergency interventions are required:

  1. Emergency Capital Transfusion (Equity Injection): The directors and Persons with Significant Control (PSCs) must consider injecting fresh equity into the business. This would directly lower the cholesterol (creditor debt) and bulk up the muscle mass (net assets), moving the balance sheet out of the negative equity danger zone.
  2. Debt Restructuring (Arterial Clearance): Negotiate extended payment terms with the £98.5k worth of creditors. If the business can stretch its payable days without defaulting, it will relieve the immediate pressure on its working capital.
  3. Cash Flow Triage: Conduct an immediate review of overheads and margins. With zero employees and rising liabilities, the pricing strategy or cost base needs surgical intervention to ensure every sale contributes positively to cash flow.
  4. Monitor for Director Loan Accounts: Given the PSC structure, it is vital to check if the liabilities include loans from the directors. If the £98.5k includes director loans, these could be subordinated (pushed to the back of the queue), which would artificially improve the outward financial health to external trade creditors.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 24 September 2026